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Editorial
In January 2009, after 8 years of planning and development, the 
National Children’s Study (NCS; http://www.  nationalchildrensstudy. 
gov/Pages/default.aspx) will begin enrollment and data collection at the 
first of the initial, or Vanguard, locations, in Duplin County, North 
Carolina, and in Queens, New York. In spring 2009, the remaining 
five Vanguard locations will join them, followed by 29 additional 
  locations in 2010 and more in the following 2 years.
The NCS, a national longitudinal cohort study of 100,000 children 
to be followed from early pregnancy to adulthood, will examine how 
environmental exposures, interacting with genetic factors and medical 
access, affect children’s health and development. Beginning enrollment 
caps a remarkable journey from a bold vision to a reality that was some-
times unpredictable and cloaked in uncertainty. 
The NCS began after assertions from both the President’s Task Force 
on Environmental Health and Safety Risks to Children and the Children’s 
Health Act of 2000 that a multi  agency consortium should carry out a large 
longitudinal study. Since its inception, the planning and development of the 
NCS have been led by the National Institute of Child Health and Human 
Development, along with a consortium of lead agencies that includes the 
National Institute of Environmental Health Sciences, the Centers for Disease 
Control and Prevention, and the U.S. Environmental Protection Agency. 
With broadly defined environmental exposures and all of children’s health 
and developmental outcomes of concern, the NCS calls for equally broad 
input by scientific experts, communities, and involved groups. To meet this 
need, the study has committed to gathering the best input possible through 
its Federally Chartered Advisory Committee; Interagency Coordinating 
Committee; over 20 working groups representing > 2,500 clinicians, scien-
tists, and community members; public, peer, and agency reviews; and active 
participation by the network of Study Centers across the country. 
The NCS  provides opportunities for related investigations by affili-
ated and nonaffiliated investigators through adjunct studies conducted 
at NCS study locations or through analysis of data collected in the 
NCS to address a wide range of additional questions beyond the core 
study hypotheses. The study can be expanded to cover even broader 
maternal, fetal, and child health research. The processes for thoroughly 
considering the development of methods, proposed changes, and 
ongoing input are being established through working teams composed 
of scientists at the various Study Centers, federal agencies, and else-
where. These teams are organized according to the various issues being 
addressed in the NCS,  such as genetics/epigenetics and genomics/epig-
enomics, health disparities, environmental exposure, neuro  development 
and cognition, nutrition, and physical/clinical measures.
The nationally representative sampling strategy is probably the 
most unique and demanding challenge. A representative sample offers 
the best opportunity to apply the findings of the NCS to all children 
in the United States. Enrolling and retaining a representative sample 
of participants will require full engagement of all of the communities 
involved. Thus, this national study must also become a community 
study at the level of participating neighborhoods and counties, with 
input and ownership by community advisory boards, community orga-
nizations and institutions, and local citizens. 
In spite of the size and the breadth of the NCS, it cannot meet 
all of the needs and expectations of its supporters. A sample with   
100,000 subjects will, by its very size and cost, limit the depth and 
complexity of many measures. The sample size may prohibit many 
specialized procedures and technologies, and many questions that 
investigators want to ask will also be beyond the reach of this study.
The advantages of the NCS that other studies cannot do are its capac-
ity to address compelling problems that are uncommon and to examine 
interactions between various environmental exposures and genetic factors 
that require a large sample and detailed measures of multiple exposures 
and outcomes across life stages. The capability to study possible effects 
and relationships of many exposure factors on multiple outcomes pro-
vides both considerable cost-effectiveness and research opportunities not 
other  wise available. Access to the necessary resources will be an ongoing 
challenge, dependent upon many factors, especially the ability of the 
NCS to fulfill its promise.
Findings from the NCS will ultimately benefit all Americans by 
providing researchers, health care providers, and public health offi-
cials with information from which to develop prevention strategies, 
health and safety guidelines, and possibly new treatments and cures 
for disease. As we mark the true beginning of this ambitious study, it 
is appropriate to recognize that the NCS belongs to all of us—scientists, 
communities, and families. Realizing its goals will require our continued 
effort, investment, and ownership. 
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